RxDoctor Payments Data

Haroon Siddique, MD

Psychiatry · Decatur, TXNPI 1457461519

Payments from drug & device makers

$11,460in general payments, 2019–2025

Across 814 payments — averaging $14.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Sunovion Pharmaceuticals Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$1K
  • plus $3K from 18 others

What the payments were for

  • Food & beverage$11,38899%
  • Education$711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,460 in reported general payments places this provider in the 90th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$227,779
Medicare patients
412
Services billed
2,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$101,982
VraylarCariprazine Hcl45$65,430
RexultiBrexpiprazole19$41,910
Lurasidone Hcl74$5,623
Aripiprazole112$5,292
TrintellixVortioxetine Hydrobromide11$4,705
Duloxetine Hcl151$3,816
Desvenlafaxine Succinate ErDesvenlafaxine Succinate100$2,771
Bupropion XlBupropion Hcl128$2,724
Vilazodone Hcl34$2,545
Atomoxetine Hcl22$2,313
Acamprosate Calcium23$2,203
Quetiapine Fumarate194$1,365
Trazodone Hcl238$1,277
Olanzapine89$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$1,676$101,98214 claims
AbbVieVraylar$1,535$65,43045 claims
Otsuka America Pharmaceutical, Inc.Rexulti$1,001$41,91019 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$237$4,70511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Decatur

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →